Clinical trials, decentralised by default.
Full-service and FSP support for interventional studies (efficacy, safety and tolerability), with hybrid and virtual designs as standard.
When timelines are tight, recruitment decides the programme.
Poor recruitment and retention is the most common cause of trial delay: the science holds, the reach does not. A protocol that only opens at research centres competes for the same participants everyone else is chasing.
A study loses time in more than one place. We work on all of them.
Enrolment is the constraint sponsors talk about most, and it is rarely the only one. Time is lost across the whole arc — and each loss has a design answer.
Start-up and site activation
Regulatory submissions, ethics packages, contracts and site qualification run in parallel rather than in sequence, on templates already accepted in previous studies.
Reaching participants
A study designed to reach people where they already are — at home, through community clinicians, in pharmacies — draws from a wider pool from day one, beyond the catchment of any single centre.
How Reach worksKeeping them enrolled
Retention is the quietest cost of all. When visits fit an ordinary week, participants stay in the study and the timeline holds.
LucaH®Data as it happens
Captured at source and validated on entry, so queries fall due during the study rather than accumulating for the end of it.
Capture in ECS®Closing the database
Ongoing cleaning and a single source of truth turn database lock from an event into the end of a continuous process.
The design decides the timeline long before the first data point.
Decentralised execution, one source of truth.
- Phygital recruitmentPHYGITAL-CROWD reaches multi-country populations traditional sites miss, and keeps them adherent.
- Efficacy, safety & tolerabilityHuman efficacy trials plus safety and tolerability studies, designed to the evidence bar each product needs.
- Decentralised executionVirtual, hybrid or site-based on one system, built around ICH E6(R3) and FDA DCT guidance.
- Pre-activated sitesInvestigators and HCPs with channels already open, so activation accelerates.
- One source of truthThe Capture layer of ECS® unifies ePRO, eConsent, EDC-EHR and lab data, no double entry.
Meeting patients where they are.
Every study sits somewhere along a continuum, from fully virtual to fully on-site. We design each protocol at the point on that continuum where evidence quality and patient burden are best balanced.
Continuity of ownership, and freedom of technology choice.
- Freedom of technology choice means faster, cleaner ECS®-run studies.
- An Expert team that keeps your programme first, start to finish.
- Decentralisation keeps patients close to trusted doctors, lifting retention.
- ViSA enables centralised remote monitoring without losing oversight.
From site-heavy to participant-first.
Centralised, site-less and phygital, the trial configuration bends to the participant. One operating layer, real oversight, defensible data.
Move your next study faster.
Bring us the protocol. We'll show you a phygital execution plan that cuts recruitment risk from day one.